UAE

Life and Living

World

Opinion

Business

Sports

Entertainment

Dubai World Cup

lifestyle

Travel

Reviews

Brands

Supplements

KT Events

KT APPDOWNLOAD

Explainer: World Health Organization's struggle for a global Covid-19 vaccine plan

Here is a look at the WHO's plan and the approaches by wealthier nations.

By Reuters

  • Follow us on
  • google-news
  • whatsapp
  • telegram
The Covax global vaccines facility is a program designed to pool funds from wealthier countries and nonprofits to develop a Covid-19 vaccine and distribute it equitably around the world. Its aim is to deliver 2 billion doses of effective, approved Covid-19 vaccines by the end of 2021.
The Covax global vaccines facility is a program designed to pool funds from wealthier countries and nonprofits to develop a Covid-19 vaccine and distribute it equitably around the world. Its aim is to deliver 2 billion doses of effective, approved Covid-19 vaccines by the end of 2021.
The details of the program are still being hashed out ahead of an Aug. 31 deadline for nations to join. It is led by the WHO, along with the Gavi vaccine alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI).
The details of the program are still being hashed out ahead of an Aug. 31 deadline for nations to join. It is led by the WHO, along with the Gavi vaccine alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI).
Covax is part of a broader program, called the Access to Covid-19 Tools (ACT) Accelerator, that works to ensure that vaccines, treatments, diagnostic tests and other healthcare resources are broadly available to combat the pandemic.
Covax is part of a broader program, called the Access to Covid-19 Tools (ACT) Accelerator, that works to ensure that vaccines, treatments, diagnostic tests and other healthcare resources are broadly available to combat the pandemic.
They have focused on securing vaccines for their own citizens, striking deals for the first doses even as data has yet to prove the vaccines to be effective.
They have focused on securing vaccines for their own citizens, striking deals for the first doses even as data has yet to prove the vaccines to be effective.
Governments including United States, the United Kingdom, Japan, and the European Union have spent tens of billions of dollars on deals with vaccine makers such as Pfizer Inc, Johnson & Johnson, AstraZeneca Plc and others. The United States alone has committed nearly $11 billion for development, testing, manufacture and stockpiling of hundreds of millions of doses. <p></p>Russia and China are also working on vaccines and have already begun vaccinating some of their citizens.
Governments including United States, the United Kingdom, Japan, and the European Union have spent tens of billions of dollars on deals with vaccine makers such as Pfizer Inc, Johnson & Johnson, AstraZeneca Plc and others. The United States alone has committed nearly $11 billion for development, testing, manufacture and stockpiling of hundreds of millions of doses. <p></p>Russia and China are also working on vaccines and have already begun vaccinating some of their citizens.
The ACT Accelerator is financed by a variety of nonprofits and governments. It is aiming to raise about $31 billion. So far, the Covax facility has attracted interest from 92 poorer countries hoping for voluntary donations and 80 wealthier countries, a number little changed from a month ago, that would finance the scheme, according to the WHO.
The ACT Accelerator is financed by a variety of nonprofits and governments. It is aiming to raise about $31 billion. So far, the Covax facility has attracted interest from 92 poorer countries hoping for voluntary donations and 80 wealthier countries, a number little changed from a month ago, that would finance the scheme, according to the WHO.
The WHO has expressed concern that wealthier countries hoarding vaccines for their own citizens could impede efforts to end the pandemic.
The WHO has expressed concern that wealthier countries hoarding vaccines for their own citizens could impede efforts to end the pandemic.
“We need to prevent vaccine nationalism,” WHO chief Tedros Adhanom Ghebreyesus said during a Tuesday virtual briefing. “Sharing finite supplies strategically and globally is actually in each country’s national interest.”
“We need to prevent vaccine nationalism,” WHO chief Tedros Adhanom Ghebreyesus said during a Tuesday virtual briefing. “Sharing finite supplies strategically and globally is actually in each country’s national interest.”

Published: Wed 19 Aug 2020, 7:24 AM

Last updated: Wed 19 Aug 2020, 12:51 PM

WHO leaders have said that developing a coordinated global distribution system for Covid-19 vaccines that prioritise those at greatest risk of getting sick, such as healthcare workers, would help curb the spread of coronavirus worldwide.
WHO leaders have said that developing a coordinated global distribution system for Covid-19 vaccines that prioritise those at greatest risk of getting sick, such as healthcare workers, would help curb the spread of coronavirus worldwide.

Latest Photos

  • Category

  • Sort By